tiprankstipranks
Advertisement
Advertisement

AU:RAD Stock Latest News

Radiopharm Theranostics advances radiopharmaceutical pipeline with key trial milestones
Company AnnouncementsRadiopharm Theranostics advances radiopharmaceutical pipeline with key trial milestones
6d ago
RAD
Radiopharm announces new data from Phase 0/1 HEAT trial
PremiumThe Fly
Radiopharm announces new data from Phase 0/1 HEAT trial
9d ago
RADX
Radiopharm Unveils Encouraging First-in-Human Data for HER2 Radiopharmaceutical 177Lu-RAD202
PremiumCompany Announcements
Radiopharm Unveils Encouraging First-in-Human Data for HER2 Radiopharmaceutical 177Lu-RAD202
9d ago
RAD
Radiopharm completes U.S. Phase 2b enrolment for RAD 101 brain metastasis imaging trial
PremiumCompany Announcements
Radiopharm completes U.S. Phase 2b enrolment for RAD 101 brain metastasis imaging trial
13d ago
RAD
Radiopharm gets DSMC recommendation to advance 177Lu-RAD202 to next dose
PremiumThe Fly
Radiopharm gets DSMC recommendation to advance 177Lu-RAD202 to next dose
21d ago
RADX
Radiopharm Director Adjusts Share and Option Holdings
PremiumCompany AnnouncementsRadiopharm Director Adjusts Share and Option Holdings
29d ago
RAD
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
RADX
SMMT
Buy Rating on RADX Driven by Promising RAD 101 Phase 2b Imaging Data and Clear 2026 Clinical Milestones
Premium
Ratings
Buy Rating on RADX Driven by Promising RAD 101 Phase 2b Imaging Data and Clear 2026 Clinical Milestones
1M ago
RADX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
RADX
Radiopharm’s RAD101 Hits 90% Concordance in Phase 2b Brain Metastases Trial
PremiumCompany Announcements
Radiopharm’s RAD101 Hits 90% Concordance in Phase 2b Brain Metastases Trial
1M ago
RAD
Radiopharm Theranostics to spotlight oncology pipeline at NWR Virtual Healthcare Conference
PremiumCompany Announcements
Radiopharm Theranostics to spotlight oncology pipeline at NWR Virtual Healthcare Conference
1M ago
RAD
Radiopharm Theranostics Narrows Asset Base as Half-Year Loss Widens, Increases Stake in MD Anderson JV
PremiumCompany Announcements
Radiopharm Theranostics Narrows Asset Base as Half-Year Loss Widens, Increases Stake in MD Anderson JV
2M ago
RAD
Radiopharm doses first patient in Phase 1/2a study of BetaBart
PremiumThe FlyRadiopharm doses first patient in Phase 1/2a study of BetaBart
2M ago
RADX
Radiopharm’s New 161Tb-RAD402 Trial Puts AU:RAD in Focus for Prostate Cancer Investors
Premium
Company Announcements
Radiopharm’s New 161Tb-RAD402 Trial Puts AU:RAD in Focus for Prostate Cancer Investors
3M ago
RAD
Radiopharm reports cash balance of $34.52M as of December 31
Premium
The Fly
Radiopharm reports cash balance of $34.52M as of December 31
3M ago
RADX
Radiopharm Theranostics Posts Solid Cash Runway and Positive Interim Data for Lead Brain Metastases Imaging Agent
PremiumCompany Announcements
Radiopharm Theranostics Posts Solid Cash Runway and Positive Interim Data for Lead Brain Metastases Imaging Agent
3M ago
RAD
Radiopharm’s New Phase 1 Imaging Trial Puts LRRC15-Targeted Radiotherapy in Focus
PremiumCompany Announcements
Radiopharm’s New Phase 1 Imaging Trial Puts LRRC15-Targeted Radiotherapy in Focus
3M ago
RAD
Radiopharm increases ownership in Radiopharm Ventures to 87.5%
PremiumThe Fly
Radiopharm increases ownership in Radiopharm Ventures to 87.5%
4M ago
RADX
Radiopharm Theranostics Options Lapse, Trimming Potential Dilution
PremiumCompany Announcements
Radiopharm Theranostics Options Lapse, Trimming Potential Dilution
4M ago
RAD
Radiopharm Theranostics Increases Director Paul Hopper’s Option Holdings After AGM Approval
PremiumCompany AnnouncementsRadiopharm Theranostics Increases Director Paul Hopper’s Option Holdings After AGM Approval
4M ago
RAD
Radiopharm Theranostics Increases Director Ian Turner’s Option Holdings After Shareholder Approval
Premium
Company Announcements
Radiopharm Theranostics Increases Director Ian Turner’s Option Holdings After Shareholder Approval
4M ago
RAD
Radiopharm Theranostics Issues 99.3 Million Unquoted Options Under Employee Incentive Scheme
Premium
Company Announcements
Radiopharm Theranostics Issues 99.3 Million Unquoted Options Under Employee Incentive Scheme
4M ago
RAD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >